Stocks and Investing Stocks and Investing
Tue, August 9, 2016
[ 12:00 AM ] - WOPRAI
William Wallace Upgraded (TBBK) to Strong Buy on, Aug 9th, 2016
[ 12:00 AM ] - WOPRAI
John Roberts Maintained (CC) at Strong Sell with Increased Target to $5.25 on, Aug 9th, 2016
Mon, August 8, 2016
[ 12:00 AM ] - WOPRAI
Frank Louthan Downgraded (CCOI) to Hold on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Steven Chercover Downgraded (WY) to Hold and Held Target at $33 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (WY) at Strong Buy with Increased Target to $37 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Michael Petusky Downgraded (XRAY) to Hold on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Matthew Breese Downgraded (VLY) to Hold on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Nicholas Joseph Maintained (VTR) at Hold with Increased Target to $75 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Bose George Maintained (TWO) at Buy with Increased Target to $304 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Will Randow Maintained (BLDR) at Hold with Increased Target to $14 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (BLK) at Strong Buy with Increased Target to $200 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Andrew Baum Maintained (BMY) at Strong Buy with Decreased Target to $75 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Jeffrey Holford Maintained (BMY) at Hold with Decreased Target to $69 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Gregg Gilbert Maintained (BMY) at Hold with Decreased Target to $62 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Josh Wolfson Downgraded (AEM) to Hold on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Matthew Murphy Maintained (AEM) at Buy with Increased Target to $61 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Jade Rahmani Maintained (AMH) at Hold with Increased Target to $22 on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Mark Wilde Downgraded (BCC) to Hold on, Aug 8th, 2016
[ 12:00 AM ] - WOPRAI
Gary Yu Maintained (BABA) at Buy and Held Target at $131 on, Aug 8th, 2016
Sun, August 7, 2016
[ 12:00 AM ] - WOPRAI
Alicia Yap Maintained (BABA) at Strong Buy with Increased Target to $104 on, Aug 7th, 2016
[ 12:00 AM ] - WOPRAI
Vamil Divan Downgraded (BMY) to Hold and Decreased Target to $63 on, Aug 7th, 2016
Fri, August 5, 2016
[ 12:00 AM ] - WOPRAI
Amit Mehrotra Maintained (XPO) at Strong Buy with Increased Target to $42 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Brian Ossenbeck Maintained (XPO) at Buy with Increased Target to $50 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Arlinda Lee Initiated (BPMC) at Strong Buy on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Greg Konrad Maintained (TDY) at Hold with Increased Target to $105 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (TEAM) at Strong Buy with Increased Target to $39 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Ittai Kidron Maintained (TEAM) at Buy with Increased Target to $35 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Michael Rehaut Maintained (TMHC) at Hold and Held Target at $17 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Brian Fitzgerald Maintained (SSTK) at Hold with Increased Target to $60 on, Aug 5th, 2016
[ 12:00 AM ] - WOPRAI
Gena Wang Maintained (BMRN) at Buy with Increased Target to $125 on, Aug 5th, 2016

Gena Wang Maintained (BMRN) at Buy with Increased Target to $125 on, Aug 5th, 2016


Published on 2024-10-25 18:00:54 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $105 to $125 on, Aug 5th, 2016.

Gena, nor any peers, have made any analyst calls on BMRN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources